Investing in the future
Article Abstract:
Pegasus is a computer software company specializing in products for accounting. The company reported a drop in profit for 1998 due to increased investment in research and development. There are new products emerging, and Pegasus has a strong balance sheet. The company's stock price has fallen as a result of a warning about the effects of increased research spending on profits. This research should bring long-term benefits, while spending on research is likely to fall in 2000.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Division: a new dawn
Article Abstract:
Division saw a rise in its share price following its flotation in 1993, but the price later fell. The company has developed software that allows virtual reality models to be created from computer-aided designs. A graphics chip project has been sold to Hewlett Packard which had helped with its development. The company is forecast to make a small loss excluding disposals for 1995 to 1006 and a profit for 1996 to 1997 according to Albert E Sharp.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Delcam
Article Abstract:
Delcam should be able to grow in the Far East and US and is improving and widening its product base. The company faces strong competition.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The dull rally. Investing in the future of medicine
- Abstracts: Plans for the future. Penalty time at the Revenue. Tax returns made easy
- Abstracts: Moving on up. Cautious market. 100 reasons to buy
- Abstracts: Patience is a virtue. Investing in the land of opportunity. Day trading uncovered
- Abstracts: It's deja vu all over again. Oddly, the price is right. The new D&O liability crisis